Alternatively, significant differences in CCL20 expression were detected in 14 cancers, with significantly higher expression in breast invasive carcinoma, CHOL, glioblastoma multiforme, COAD, ESCA, HNSC, READ, STAD, KIRC, thyroid carcinoma (THCA), LIHC, LUAD, and uterine corpus endometrial carcinoma, and significantly lower expression in KICH (Supplementary Fig. S4A). This evidence concerns the gene CCL20 and cancer.